Skip to main content
. 2020 Jun 2;37(6):117. doi: 10.1007/s11095-020-02844-6

Table I.

Advantages and disadvantages of administration routes for protein, peptide and antibody based therapeutics. Created from information provided in (28)

Route of administration Advantages Disadvantages
Parenteral

Intravenous route offers 100% bioavailability

Rapid delivery of drug into systemic circulation

Viable alternative if oral route is not feasible

Intravenous route is painful, invasive and poorly tolerated by patients

Potential for toxic effects due to repeated administration

Oral

Painless

Convenient

Potential for poor permeability across the intestinal epithelial membrane

First pass metabolism

Proteases present in the gastrointestinal tract may degrade drug

Pulmonary

Painless

Large surface area available for protein absorption

Avoids first pass metabolism

Low enzyme activity in the lungs

Potential for poor permeability across epithelial lining fluid, epithelial cell layer and the endothelial membrane of capillary cells

Proteins and peptides may be subjected to phagocytosis by the macrophages in the lungs

Ocular Avoids first pass metabolism

Potential for poor permeability, particularly of hydrophilic macromolecules, across eye membrane

High enzyme activity, i.e. protease and aminopeptidase

Nasal

Painless

Large surface area available for protein absorption

Avoids first pass metabolism

Thin porous endothelial basement membrane of the nasal epithelium facilitates drug absorption

Potential for poor permeability, particularly of large hydrophilic macromolecules, across nasal epithelium

Rapid mucociliary clearance that reduces the available time for drug absorption

Only small amounts of drug can be administered via the nasal route

Rectal Offers partial bypass of first pass metabolism

Potential for poor permeability across rectal epithelium

Patient may consider this route distasteful

Transdermal

Painless

Convenient

Large surface area available for protein absorption

Avoids first pass metabolism

Potential for adaptability to deliver both small and macromolecular therapeutics, e.g. by using microneedles

Potential for poor permeability, particularly of large hydrophilic molecules, across the stratum corneum

Potential for localised skin irritation